These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1372329)

  • 1. Increase of peripheral B lymphocytes committed to the production of monoreactive and high affinity antibodies to HTLV-1 in patients with HAM/TSP.
    Nakamura M; Itoyama Y; Kuroki M; Nakano S; Kondoh S; Nagafuchi S; Kira J; Ichinose I; Mitsugi K; Anzai K
    J Neuroimmunol; 1992 Mar; 37(1-2):35-45. PubMed ID: 1372329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load.
    Kira J; Nakamura M; Sawada T; Koyanagi Y; Ohori N; Itoyama Y; Yamamoto N; Sakaki Y; Goto I
    J Neurol Sci; 1992 Jan; 107(1):98-104. PubMed ID: 1578240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.
    Nakamura M; Kuroki M; Kira J; Itoyama Y; Shiraki H; Kuroda N; Washitani Y; Nakano S; Nagafuchi S; Anzai K
    J Neuroimmunol; 1991 Dec; 35(1-3):167-77. PubMed ID: 1955565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of the antibody response to the HTLV-I gag and env proteins in HTLV-I asymptomatic carriers and HAM/TSP patients: an isotype and subclass analysis.
    Dekaban GA; King EE; Arp J; Palker TJ; Rice GP
    Scand J Immunol; 1994 Aug; 40(2):171-80. PubMed ID: 8047838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S
    Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-1 antibody class and subclass distribution in African TSP and control populations.
    Verdier M; Bonis J; Leonard G; Dumas M; Denis F
    J Neuroimmunol; 1993 Jan; 42(1):117-20. PubMed ID: 8423204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
    Jacobson S; Reuben JS; Streilein RD; Palker TJ
    J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Furukawa Y; Bangham CR; Taylor GP; Weber JN; Osame M
    Clin Exp Immunol; 2000 May; 120(2):307-16. PubMed ID: 10792381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.
    Lal RB; Buckner C; Khabbaz RF; Kaplan JE; Reyes G; Hadlock K; Lipka J; Foung SK; Chan L; Coligan JE
    Clin Immunol Immunopathol; 1993 Apr; 67(1):40-9. PubMed ID: 7680300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
    J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of intrathecal IgG synthesis for HTLV-1 core and envelope proteins in HAM/TSP.
    Kitze B; Puccioni-Sohler M; Schäffner J; Rieckmann P; Weber T; Felgenhauer K; Bodemer W
    Acta Neurol Scand; 1995 Sep; 92(3):213-7. PubMed ID: 7484074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.
    Elovaara I; Koenig S; Brewah AY; Woods RM; Lehky T; Jacobson S
    J Exp Med; 1993 Jun; 177(6):1567-73. PubMed ID: 8496677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential recognition of synthetic peptides from HTLV-I gp21 envelope protein by HLA-DRB1 alleles associated with HAM/TSP (HTLV-I-associated myelopathy/tropical spastic paraparesis).
    Yamano Y; Kitze B; Yashiki S; Usuku K; Fujiyoshi T; Kaminagayoshi T; Unoki K; Izumo S; Osame M; Sonoda S
    J Neuroimmunol; 1997 Jun; 76(1-2):50-60. PubMed ID: 9184632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal molecular mimicry in immune-mediated neurologic disease.
    Levin MC; Krichavsky M; Berk J; Foley S; Rosenfeld M; Dalmau J; Chang G; Posner JB; Jacobson S
    Ann Neurol; 1998 Jul; 44(1):87-98. PubMed ID: 9667596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary involvement in patients with human T lymphotropic virus type 1-associated myelopathy: the presence of specific IgA antibody in bronchoalveolar lavage fluid.
    Sugimoto M; Imamura F; Matsumoto M; Sonoda E; Cho I; Ando M
    Am J Trop Med Hyg; 1993 Jun; 48(6):803-11. PubMed ID: 8333573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface phenotype of in vitro proliferating lymphocytes in HTLV-I-associated myelopathy (HAM/TSP).
    Eiraku N; Ijichi S; Yashiki S; Osame M; Sonoda S
    J Neuroimmunol; 1992 Apr; 37(3):223-8. PubMed ID: 1560112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T-lymphotropic virus type I (HTLV-I)-specific antibodies and cell-free RNA in crevicular fluid-rich saliva from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy.
    Soto-Ramirez LE; Garcia-Vallejo F; Renjifo B; Vergara A; Borrero I; Marlink R; Essex M
    Viral Immunol; 1995; 8(3):141-50. PubMed ID: 8833267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
    Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
    J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing.
    Kalume F; Lee SM; Morcos Y; Callaway JC; Levin MC
    J Neurosci Res; 2004 Jul; 77(1):82-9. PubMed ID: 15197740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.